Tolerability of Single-Agent Sorafenib in the Treatment of Elderly Patients With Hepatocellular Carcinoma (HCC)

Letter/Communication

Edoardo Francini and Vincenzo Bianco

Hepatology (Baltimore, Md.), Vol.60(2), pp.764-765

08/2014

DOI: 10.1002/hep.26921

PMID: 25187926

View Online

Gastroenterology & Hepatology

Life Sciences & Biomedicine

Science & Technology

Title: Subtitle: Tolerability of Single-Agent Sorafenib in the Treatment of Elderly Patients With Hepatocellular Carcinoma (HCC)
Creators: Edoardo Francini - Sapienza University of Rome
Vincenzo Bianco - Sapienza University of Rome
Resource Type: Letter/Communication
Publication Details: Hepatology (Baltimore, Md.), Vol.60(2), pp.764-765
DOI: 10.1002/hep.26921
PMID: 25187926
ISSN: 0270-9139
eISSN: 1527-3350
Publisher: Lippincott Williams & Wilkins
Number of pages: 2
Language: English
Date published: 08/2014
Academic Unit: Internal Medicine
Record Identifier: 9985221244302771

1 Record Views